methamphetamine has been researched along with ly 274614 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fuller, RW; Hemrick-Luecke, SK; Ornstein, PL | 1 |
| Asif Nazir, K; Chen, G; Fang, J; Gao, B; Li, T; Liang, M; Liu, X; Qian, H; Qiao, C; Shang, Q; Wang, J; Xiao, J; Yang, C; Yin, J; Zhang, P | 1 |
2 other study(ies) available for methamphetamine and ly 274614
| Article | Year |
|---|---|
Protection against amphetamine-induced neurotoxicity toward striatal dopamine neurons in rodents by LY274614, an excitatory amino acid antagonist.
Topics: Amino Acids; Amphetamine; Animals; Corpus Striatum; Dizocilpine Maleate; Dopamine; Dose-Response Relationship, Drug; Iprindole; Isoquinolines; Male; Methamphetamine; Mice; Nervous System Diseases; Neurons; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate | 1992 |
LY235959 attenuates development phase of Methamphetamine-Induced behavioral sensitization through the PP2A/B - AKT cascade in the dorsal striatum of C57/BL6 mice.
Topics: Animals; Behavior, Animal; Central Nervous System Stimulants; Isoquinolines; Methamphetamine; Mice; Mice, Inbred C57BL; Protein Phosphatase 2; Proto-Oncogene Proteins c-akt | 2022 |